| Product Specs | Description |
|---|---|
| Manufacturer Name | Grifols |
| Indications | Indicated in patients with hereditary antithrombin deficiency for treatment and prevention of thromboembolism and for prevention of perioperative and peripartum |
| Contraindications | None known |
| Manufacturing Methods | Plasma-derived. Thrombate III is made from large pools of human plasma donated at centers with the US. |
| Viral Safety Process | Heat treatment in solution at 60°C ± 5°C for not less than 10 hours. Nanofiltration for effective removal of viruses as small as 18 nm. |
| Route of Administration | Bolus intravenous infusion (over 10-20 minutes) |
| Product Half-Life | 3.8 days ± 1.8 days |
| Storage Requirements/Shelf Life |
|
| Available Formulations | 10 mL |
